Read the latest positive news, breakthroughs, and inspiring stories about alcohol use disorder, curated daily by BrightWire.
A daily pill form of semaglutide (the drug in Ozempic) helped people with alcohol use disorder drink less heavily in a University of Colorado trial. The breakthrough suggests these medications could offer new hope for treating addiction beyond their current uses.
Semaglutide, the active ingredient in Ozempic and Wegovy, helped people with obesity reduce heavy drinking days by 41% in a groundbreaking six-month trial. This marks the first randomized study testing GLP-1 drugs for alcohol use disorder treatment.
